LVH, HF, arrhythmias, myocardial infarction (MI) and vascular alterations such as stroke and vascular calcification are the most common adverse and fatal cardiac events studied in relation to FGF-23 (Table 2). Here, FGF23 is linked to cardiac arrhythmia.